On the problem of neuropathic pain component diagnosis in patients with cancer pain syndrome
Neuropathic pain component occurs in every second patient with pain syndrome caused by a malignant tumor. Detection of the neuropathic component of pain syndrome is crucial for selection of effective analgesia.The review presents an application algorithm for an updated system of neuropathic pain component assessment in oncological patients.
Authors
- A. M. Dorozhenko (ORCID: https://orcid.org/0000-0002-0059-326X)
- O. Yu. Barysheva (ORCID: https://orcid.org/0000-0001-6317-1243)
- Arina P. Spasova (ORCID: https://orcid.org/0000-0002-2797-4740)
- E. V. Goncharova (ORCID: https://orcid.org/0000-0003-4789-7460)
- A. N. Burganova
- A. A. Ryazankina
Institutions
- Petrozavodsk State University (RU)
- First Pavlov State Medical University of St. Petersburg (RU)
- Ministry of Health of the Russian Federation (RU)
Publication Details
- Journal
- Podderživaûŝaâ terapiâ v onkologii.
- Published
- 2024-10-02
- DOI
- https://doi.org/10.17650/3034-2473-2024-1-2-45-54
- Primary Topic
- Pain Management and Opioid Use
- Type
- article
- Field-Weighted Citation Impact
- 0.00